Duramed Cenestin
Executive Summary
Solvay will co-promote Duramed's synthetic conjugated estrogens, A product with approximately 175 reps beginning Oct. 11. Duramed's 122 reps will co-promote Solvay's Estratest/Estratest HS (esterified estrogens and methyltestosterone), a and Prometrium (progesterone). Both companies will retain the revenues from their respective products. Solvay has the option to purchase between 1.7 mil. and 3 mil. shares of Duramed stock at $9 per share